Tagged with AAM

PharmaBoardroom’s 10 Most Read Interviews of 2022
Heated Dispute Over Drug Pricing in New Inflation Reduction Act
New Perspectives on Access to Medicines
Dan Leonard & Erik C. Komendant – Association for Accessible Medicines
AAM’s Access! 2022: Five Key US Generic & Biosimilar Market Trends
US Generics & Biosimilars: Five Takeaways from Access! 2021
Dan Leonard – President & CEO, Association for Accessible Medicines (AAM)
Securing the Conditions to Secure Our Meds
The Long Read: Innovation, Access & Affordability in the USA
The Value Proposition of Generics & Biosimilars in the USA
Biosimilar Adoption in the US: Still Lagging Behind Europe
How US Generics Firms are Responding to COVID-19 Supply Chain Risks
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here